Oticon Zeal vs Otofonix Encore

The Oticon Zeal is a premium invisible-in-ear prescription hearing aid priced at $4,798. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.7/5, placing it in the top 11% of prescription hearing aids tested and ranking #5 of 36 devices in its category. Speech performance is where the Zeal truly excels. It achieved an excellent 4.9/5 in speech-in-quiet testing, scoring 1.56 points above the category average—among the strongest results we've measured. Speech-in-noise performance is solid at 3.0/5, which is 1.08 points above the category average of 1.96/5, making it notably better than typical prescription aids in challenging listening environments. Music streaming quality scores 3.3/5, sitting 0.66 points above category average and providing solid fidelity for phone audio. However, the Zeal shows some limitations in other areas. Own-voice comfort is mixed at 2.0/5, falling 0.75 points below the category average—users sensitive to how their own voice sounds may notice this. Feedback handling, while solid in absolute terms at 3.3/5, measures 1.41 points below the category average of 4.71/5. The Zeal is best suited for users who prioritize outstanding speech clarity in both quiet and moderately noisy settings, and who value quality audio streaming. Those particularly sensitive to own-voice perception or who need maximum feedback stability may want to discuss these tradeoffs with their hearing care provider.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.